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bronchitis, wheezing bronchitis, and 
pneumonia.
In the context of the previous 
reports of WUPyV detection in Aus-
tralia and North America (3), our data 
suggest a worldwide distribution of 
WUPyV. Most of the WUPyV-pos-
itive children were <4 years of age, 
and WUPyV DNA was rarely found in 
children >6 years of age. This age dis-
tribution is compatible with WUPyV 
infection occurring in day nurseries 
and kindergartens. In keeping with the 
ﬁ  ndings of Gaynor et al. (3), we ob-
served a high number of co-infections. 
The true number of co-infections in 
our study is probably higher than the 
reported 53.2%  because we did not 
test for several respiratory pathogens, 
such as coronaviruses, rhinoviruses, 
enteroviruses, and the human metap-
neumovirus. Hypotheses to account 
for the detection of WUPyV in respi-
ratory samples include the following: 
WUPyV is a persisting asymptom-
atic virus that is detected by chance, 
WUPyV is a persisting virus that is 
reactivated by an inﬂ  ammatory pro-
cess, or WUPyV is a predisposing or 
aggravating factor of respiratory dis-
eases. Further studies are necessary to 
determine whether WUPyV is a hu-
man pathogen.
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Hepatitis E, Central 
African Republic  
To the Editor: Outbreaks of 
hepatitis E virus (HEV) have been 
documented in many geographic re-
gions and nonindustrialized countries 
(1–3); they have been primarily as-
sociated with fecal contamination 
of drinking water (4). In the Central 
African Republic (CAR), economic 
indicators (CAR ranks 172/177 coun-
tries on the 2006 United Nations De-
velopment Program Human Devel-
opment Index), political instability, 
geographic situation, a deteriorating 
health network, and a very poor epi-
demiologic surveillance system all 
contribute to the country’s epidemic 
susceptibility. 
In July 2002, Ministry of Health 
(MoH) and Médecins sans Frontières 
(MSF) teams working in the Begoua 
Commune Health Center, north of 
CAR’s capital Bangui, reported an 
increased number of patients from 
the Yembi I neighborhood who were 
showing signs of jaundice and ex-
treme fatigue. 
Patients suspected of having hepa-
titis E were deﬁ  ned as those with clini-
cal jaundice (yellow discoloration of 
the sclera) and symptoms of malaise, 
anorexia, abdominal pain, arthralgia, 
and fever. Conﬁ  rmed cases were those 
in which patients’ serum samples were 
positive for HEV immunoglobulin 
(Ig) M or IgG.
Initially, 16 pairs of serum and 
stool samples were collected from 
jaundiced patients. Fecal samples 
were stored at –20°C and sent to the 
National Reference Center of Enteri-
cally Transmitted Hepatitis, Hospital 
Val de Grâce (Paris, France) for HEV 
marker testing; serum samples were 
tested at the Bangui Pasteur Institute 
for yellow fewer (YF) IgM by MAC-
ELISA. 
The HEV epidemic was con-
ﬁ  rmed by the detection of HEV mark-
ers: HEV IgG (Enzyme Immuno As-
say, HEV, Abbott Laboratories, Abbott 
Park, IL, USA), HEV IgM (Abbott 
Laboratories), ampliﬁ   cation of RNA 
(5), and the absence of YF IgM. The 
HEV genome was detected in 4 of 
the fecal samples. Genotyping and 
sequencing showed that one of these 
was genotype 1, prevalent in Africa; 
the others were related to genotype 
2 (Mexico-like) (GenBank accession 
nos. DQ151640, DQ151640) (5,6).
Data suggest that the epidemic 
began in the Yembi I neighborhood, 
then spread to the rest of the Begoua 
commune and ﬁ  nally to Bangui or sur-
rounding areas (Figure). Of 715 sus-
pected HEV case-patients recorded in 
the MSF hospital between July 22 and 
October 25, 2002, 552 (77%) lived in 
the Begoua commune (271 in the Yem-
bi I neighborhood). The attack rate for 
the Begoua commune (20,080 inhab-
itants) was 2.7%. Of 351 suspected 
case-patients serologically tested for 
IgG and IgM anti-HEV antibodies, 
222 (63%) had IgM antibodies, in-
cluding 5/16 pregnant women (2.3% 
of all conﬁ  rmed cases). Most patients 
reported jaundice (97.5%) and cholu-
ria (95.1%);other reported symptoms 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 4, April 2008  681 LETTERS
were nausea and vomiting (37.9%), 
dyspepsia (28.3%), and hepatomegaly 
and/or splenomegaly (26.4%). Four 
of the conﬁ  rmed case-patients died, a 
case-fatality ratio (CFR) of 1.8%; one 
was a pregnant woman (CFR 20% for 
pregnant women group). 
No signiﬁ   cant differences were 
found among conﬁ  rmed case-patients 
by sex or age-group. Seventy-seven 
(34.6%) had relatives with suspected 
HEV, and 163 (73.5%) had drunk un-
treated water from their own wells. 
These epidemiologic ﬁ  ndings 
suggest the water-borne nature of this 
outbreak. Environmental testing of 
water from 2 wells (before chlorina-
tion was implemented) showed the 
water to be unsafe to drink (i.e., heat-
resistant coliforms and aerobic bacte-
ria were present) (7). 
The outbreak was not surpris-
ing because a 1995 survey in Bangui 
showed anti-HEV antibodies in 24% of 
patients tested (8), indicating endemic 
HEV. Our results for IgG-positive pa-
tients were similar (23.2% in men and 
20.1% in women). As demonstrated 
during other outbreaks (3), we found 
no signiﬁ  cant difference between the 
distribution of HEV-positive patients 
by age or sex, although most patients 
were males (58%) and young adults 
(71% of ages 14–45 years).
The observed CFR was similar to 
that in other reported HEV outbreaks, 
in which CFR varied from 1% to 4% 
(9,10), but it was as high as >30% in 
pregnant women (9). Deliveries dur-
ing pregnancy months 6–8 in this out-
break highlight the need for close sur-
veillance of pregnant women affected 
by this disease.
We recommended application of 
preventive measures, including water 
disinfection, safe disposal of excreta, 
community health education, and the 
strengthening of case management 
and disease surveillance. For the CAR, 
free access to a safe water supply and 
drugs was the only way to achieve 
these goals.
The number of HEV cases in the 
Yembi I neighborhood declined after 
the crisis team implemented hygienic 
and chlorination measures in the dis-
trict, although the number of cases 
remained constant in other neighbor-
hoods of the commune (Figure). Deﬁ  -
nite conclusions cannot be drawn from 
this  ﬁ  nding. First, the MSF hospital 
was within the Begoua commune. 
Thus, patients from the rest of Bangui 
(outside the commune) only started 
arriving at the center for treatment af-
ter hearing about the hospital through 
broadcast messages. Second, a mili-
tary coup d’état during epidemiologic 
week 43 prevented us from conduct-
ing further surveillance.
Our results agree with international 
data on HEV outbreaks in other nonin-
dustrialized countries. However, stud-
ies to improve our understanding of this 
epidemic and to identify the main risk 
factors involved would be beneﬁ  cial.
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Figure. Suspected cases of hepatitis E virus in Begoua, Central African Republic, by 
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Rickettsia 
sibirica subsp. 
mongolitimonae 
Infection and 
Retinal Vasculitis 
To the Editor: Rickettsia sibirica 
subsp. mongolitimonae is an intracel-
lular bacterium that belongs to the spe-
cies R. sibirica (1). To date, only 11 
cases of infection with this bacterium 
have been reported (2–6). We report a 
case in a pregnant woman with ocular 
vasculitis.
A 20-year-old woman in the 10th 
week of her pregnancy was admit-
ted in June 2005 to St. Eloi Hospital 
in Montpellier, France, with an 8-day 
history of fever, eschar, hemifacial 
edema, and headache. On examina-
tion the day of admission, she had a 
fever of 38.5°C, headache, and frontal 
eschar surrounded by an inﬂ  amma-
tory halo. Painful retroauricular and 
cervical lymphadenopathies were not-
ed. Results of a clinical examination 
were otherwise within normal limits. 
No tick bite was reported by the pa-
tient, although she had been walking a 
few days before in Camargue (south-
ern France). Serologic results for R. 
conorii, R. typhi, Brucella spp., Bor-
relia spp., and Coxiella burnetii were 
negative. 
One day after admission, she re-
ported loss of vision (scotoma) in her 
right eye. She underwent a complete 
ophthalmic evaluation. Measurement 
of visual acuity and results of a slit-
lamp examination were within normal 
limits, but a funduscopic examination 
showed a white retinal macular lesion 
that corresponded in a ﬂ  uorescein an-
giograph to an area of retinal ischemia 
induced by vascular inﬂ  ammation and 
subsequent occlusion (Figure). The 
following day, a rash with a few macu-
lopapular elements developed, which 
involved only the palms of the hands 
and soles of the feet. Mediterranean 
spotted fever was suspected. Cyclines 
and ﬂ  uoroquinolones were contraindi-
cated because of her pregnancy, and the 
patient had a history of maculopapular 
rash after taking josamycin. She was 
treated with azithromycin, 500 mg/day 
for 10 days, under close surveillance. 
After 2 days of treatment, she was afe-
brile and the rash completely resolved. 
No obstetric complications occurred 
and she gave birth to a healthy boy at 
term. Two years later, the right sco-
toma remained unchanged.
Serologic tests for rickettsiosis 
were performed with an acute-phase 
serum sample and a convalescent-
phase serum sample (1 month after 
onset of symptoms). Samples were 
sent to the World Health Organization 
Collaborative Center in Marseille for 
rickettsial reference and research. Im-
munoglobulin (Ig) G and IgM titers 
were estimated by using a microim-
munoﬂ  uorescence assay; results were 
negative. Culture of a skin biopsy 
specimen from the eschar showed 
negative results.
DNA was extracted from eschar 
biopsy specimen and used as template 
in a PCR with primers complementary 
to portions of the coding sequences of 
the rickettsial outer membrane protein 
A and citrate synthase genes as de-
scribed (5). Nucleotide sequences of 
the PCR products were determined. 
All sequences shared 100% similar-
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Figure. Fluorescein angiograph of the right eye of the patient showing retinal occlusive 
vasculitis with arteriolar leakage at late phase.